How to Help Your Patients Save Money on Mebendazole: A Provider's Guide to Savings Programs

When you prescribe mebendazole (Emverm) for a patient, you've solved the clinical problem — but you may have inadvertently created a financial one. The retail price of Emverm routinely exceeds $4,000 for a standard two-tablet course, placing it among the most expensive commonly prescribed antiparasitic medications in the United States. However, with the right resources, many patients can pay far less. This guide provides everything prescribers need to help patients navigate the cost of mebendazole in 2026.

Understanding the Cost Landscape for Mebendazole in 2026

There is currently no FDA-approved generic mebendazole on the US market. Emverm (100 mg chewable tablets, Amneal Pharmaceuticals) is the sole commercially available form. Pricing at retail is as follows:

• Average retail price (no discount): $4,287–$5,258 for 2 tablets (100 mg each)
• GoodRx price: Approximately $4,287 (~18% below retail)
• Emverm Savings Program (commercially insured patients): As low as $5 per fill

This pricing disparity — $5 vs. $5,000+ — means that knowing about and directing patients to the right savings program can be genuinely life-changing for medication adherence and treatment completion.

The Emverm Savings Program: What Providers Need to Know

The Emverm Savings Program is a manufacturer-sponsored discount program offered by Amneal Pharmaceuticals. As a prescriber, here's the practical information you need to share with patients:

• Minimum patient cost: $5 per prescription fill
• Maximum savings: $80 per prescription, program valid for up to 12 uses
• Eligibility: Patients with commercial insurance only. Not eligible if covered by Medicare, Medicaid, TRICARE, or any federal/state healthcare program.
• How patients access it: Download and print a savings card at emverm.com/savings-program or call 1-877-264-2440. No insurance approval or paperwork is required — the patient just presents the card at the pharmacy.

Practical recommendation: Add the Emverm Savings Program URL and phone number to your antiparasitic prescribing workflow, or have staff include it in the patient discharge materials whenever Emverm is prescribed. The cost difference ($5 vs. $5,000+) is dramatic enough that this brief step can make the difference between a patient filling the prescription or going untreated.

Navigating Insurance Coverage and Prior Authorization

Insurance coverage for Emverm varies considerably across plans. Many plans require prior authorization (PA) before they will cover it. To help patients with PA:

1. Document the diagnosis thoroughly. Include specific ICD-10 codes: B80 (enterobiasis/pinworm), B77 (ascariasis), B76 (hookworm), B79 (trichuriasis/whipworm). Diagnostic findings (tape test results, stool studies, clinical presentation) strengthen the PA request.
2. Note contraindications to alternatives. If the patient has a reason they cannot use albendazole or other antiparasitic alternatives, document this clearly. Plans are more likely to approve PA when alternatives are contraindicated.
3. Request peer-to-peer review if denied. If the initial PA is denied, request a peer-to-peer clinical review with the plan's medical director. For a diagnosed parasitic infection, PA is often approvable with appropriate clinical justification.

Cost-Effective Alternatives for Patients on Government Insurance

For patients on Medicare, Medicaid, or other government programs who cannot access the Emverm Savings Program, consider these alternatives:

• Pyrantel pamoate (OTC): Costs $8–$15 at most pharmacies without any prescription. Effective for pinworm (enterobiasis) and hookworm. For pinworm — the most common intestinal worm infection in the US — pyrantel pamoate is a guideline-recommended treatment option.
• Generic albendazole: Effective for all four worm types mebendazole treats. Generic versions are available and, with GoodRx or SingleCare, can be obtained for as low as $37–$150 per course. Medicaid coverage for generic albendazole is more common than for Emverm.

Helping Patients Find Pharmacies That Stock Emverm

Even when patients have their savings card ready, they may struggle to find a pharmacy that has Emverm in stock. Directing patients to medfinder for providers can save significant time. medfinder contacts pharmacies in the patient's area to identify which ones have the medication in stock, then texts results to the patient. This is particularly helpful for a drug like Emverm that many large chain pharmacies don't routinely carry.

Quick Reference: Decision Framework by Insurance Type

• Commercial insurance: Prescribe Emverm + direct to Emverm Savings Program ($5/fill). Submit PA if required.
• Medicare Part D: Check plan formulary; Emverm Savings Program not eligible. Consider albendazole generic (check plan coverage) or pyrantel pamoate OTC.
• Medicaid: Check state formulary for albendazole generic. Pyrantel pamoate OTC is always accessible. Emverm Savings Program not applicable.
• Uninsured: Pyrantel pamoate OTC ($8–$15) for pinworm/hookworm. Albendazole generic with GoodRx ($37–$150) for broader coverage. Emverm at $4,287+ even with GoodRx — cost-prohibitive.